Prehypertension and the risk for cardiovascular disease in the Japanese general population: The Jichi Medical School Cohort Study

Journal of Hypertension

Volumn 28, Issue 8, 2010, Pages 1630-1637

  Ishikawa, Yukiko ^a   Ishikawa, Joji ^a,b   Ishikawa, Shizukiyo ^a   Kajii, Eiji ^a   Schwartz, Joseph E ^b   Pickering, Thomas G ^b   Kario, Kazuomi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b New York Presbyterian Morgan Stanley Children's Hospital   (United States)

Author keywords

cardiovascular disease; Japanese; population based study; prehypertension

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; POPULATION; POSTPRANDIAL STATE; PREHYPERTENSION; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE;

EID: 77954943897     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32833a8b9f     Document Type: Article

References (12)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA 2003; 289:2560-2571.
2. Ishikawa Y, Ishikawa J, Ishikawa S, Kayaba K, Nakamura Y, Shimada K, et al. Prevalence and determinants of prehypertension in a Japanese general population: the Jichi Medical School Cohort Study. Hypertens Res 2008; 31:1323-1330.
3. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in nonhypertensive participants in the Framingham heart study: a cohort study. Lancet 2001; 358:1682-1686.
4. Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006; 354:1685-1697.
5. Sekine MGE, Ochiai H, Umezu M, Ishii M. Office blood pressure in patients with essential hypertension. Ther Res 1997; 18:122.
6. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, et al. The Japanese society of hypertension guidelines for the management of hypertension (JSH 2009). Hypertens Res 2009; 32:3-107.
7. AdamsHPJr,Bendixen BH, Kappelle LJ, BillerJ,Love BB, Gordon DL,Marsh EE 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24:35-41.
8. The World Health Organization MONICA project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol 1988; 41:105-114.
9. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345:1291-1297.
10. Murakami Y, Hozawa A, Okamura T, Ueshima H, the Evidence for Cardiovascular Prevention From Observational Cohorts in Japan Research G. Relation of blood pressure and all-cause mortality in 180 000 Japanese participants: pooled analysis of 13 cohort studies. Hypertension 2008; 51:1483-1491.
11. Pletcher MJ, Bibbins-Domingo K, Lewis CE, Wei GS, Sidney S, Carr JJ, et al. Prehypertension during young adulthood and coronary calcium later in life. Ann Intern Med 2008; 149:91-99.
12. Kubo M, Kiyohara Y, Kato I, Tanizaki Y, Arima H, Tanaka K, et al. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study. Stroke 2003; 34:2349-2354.